Cleared Traditional

K901301 - STER INHAL SOLUT PREFIL BTL W/ADJUST EN...

K901301 is an FDA 510(k) clearance for STER INHAL SOLUT PREFIL BTL W/ADJUST EN..., manufactured by Automatic Liquid Packaging, Inc.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 72-day FDA review.

K901301 · Automatic Liquid Packaging, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1990
Decision
72d
Days
Class 2
Risk

K901301 is an FDA 510(k) clearance for the STER INHAL SOLUT PREFIL BTL W/ADJUST ENTRAIN NEBUL. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Automatic Liquid Packaging, Inc. (Woodstock, US). The FDA issued a Cleared decision on May 31, 1990 after a review of 72 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Automatic Liquid Packaging, Inc. devices

FDA 510(k) Submission Details - K901301

510(k) Number K901301 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 20, 1990
Decision Date May 31, 1990
Days to Decision 72 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 140d · This submission: 72d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 218
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K901301.
TRACH CARE MDI ADAPTER
K900273 · Ballard Medical Products · Aug 1990
MDI ADAPTOR
K900783 · Hudson Oxygen Therapy Sales Co. · Jul 1990
ACCESSORY FITMENT TO NEBULIZER SYSTEM, STERILE
K901362 · Automatic Liquid Packaging, Inc. · Jun 1990
IN-THE NEBULIZER
K900470 · Hudson Oxygen Therapy Sales Co. · May 1990
H.E.A.R.T. NEBULIZER
K900228 · B&B Medical Technologies, Inc. · Mar 1990
INTERTECH/INSPIRON (R) MEDICATION NEBULIZER KIT
K896923 · Intertech Resources, Inc. · Mar 1990